,Set,NGenes,Direction,PValue,FDR
1,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,1.38351024895114e-23,1.13724542463783e-20
2,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,14,Down,3.33066789874798e-09,1.36890450638542e-06
3,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,2.25848644876793e-08,6.18825286962412e-06
4,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,1.28452969441645e-07,2.18412628639275e-05
5,WP_PROSTAGLANDIN_SIGNALING,22,Down,1.32854396982528e-07,2.18412628639275e-05
6,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,37,Down,2.51443251244739e-07,3.08288540920124e-05
7,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,2.62532820734899e-07,3.08288540920124e-05
8,WP_SPINAL_CORD_INJURY,66,Down,5.10078506715678e-06,0.00052410566565036
9,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,2.00480611243223e-05,0.00183105624935477
10,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,2.48909245140433e-05,0.00204603399505436
11,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,3.5948144415186e-05,0.00268630679175299
12,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,4.97116042212249e-05,0.0034052448891539
13,WP_COMPLEMENT_ACTIVATION,12,Up,7.28373859333147e-05,0.0046055639413219
14,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Down,0.000106806035871148,0.005427444453125
15,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.000108973316602876,0.005427444453125
16,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.000110360945907623,0.005427444453125
17,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,28,Down,0.000117084358084323,0.005427444453125
18,WP_MEVALONATE_PATHWAY,7,Down,0.000124657909548722,0.005427444453125
19,WP_HYPERTROPHY_MODEL,13,Down,0.000125451879086831,0.005427444453125
20,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Down,0.000147378850998432,0.00592438867814872
21,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.000152626831241788,0.00592438867814872
22,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.000158560280923688,0.00592438867814872
23,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.000219208894220939,0.00783433526302661
24,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.000231265633464464,0.00792084794615788
25,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Down,0.000254689101979881,0.00837417767309849
26,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.00031745700688752,0.0100365253715977
27,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Down,0.000360687033859169,0.0103010454362589
28,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.000362296459306769,0.0103010454362589
29,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Down,0.000363418877921542,0.0103010454362589
30,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,78,Down,0.000495922600980032,0.0132292342755716
31,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,64,Down,0.000504604243185726,0.0132292342755716
32,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.000527630775454067,0.0132292342755716
33,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.000531100646099588,0.0132292342755716
34,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Down,0.000683469626970458,0.0165238833344034
35,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.000952195060522487,0.0221321513199761
36,WP_GASTRIN_SIGNALING,93,Down,0.000969291298685083,0.0221321513199761
37,WP_FOCAL_ADHESION,119,Down,0.00118967468723567,0.026430070078587
38,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Down,0.0012992849070192,0.0281055840413101
39,WP_IL1_SIGNALING,54,Down,0.00133461427678336,0.0281295624491262
40,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,49,Down,0.00142955040989191,0.0282799859082217
41,WP_GLYCOLYSIS_IN_SENESCENCE,11,Down,0.00143799457560264,0.0282799859082217
42,WP_REGULATION_OF_ACTIN_CYTOSKELETON,93,Down,0.00144496278363177,0.0282799859082217
43,WP_MAPK_SIGNALING,163,Down,0.00152528892773862,0.0291578488046777
44,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Down,0.0016085739256637,0.0299511706900136
45,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Down,0.00163966262901535,0.0299511706900136
46,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Up,0.00176205651893736,0.0310758401961698
47,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.00177684244430655,0.0310758401961698
48,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Down,0.00209053417716143,0.0358003977838896
49,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.00217751181943795,0.0365288717464898
50,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.00232436550196877,0.0382125688523665
51,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Down,0.00240479364782285,0.0383104221028327
52,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,75,Down,0.00242353035200401,0.0383104221028327
53,WP_AXON_GUIDANCE,37,Down,0.00260481681021144,0.0403992343017699
54,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.00272540021320337,0.0411091061374343
55,WP_TAMOXIFEN_METABOLISM,2,Up,0.00275060929143417,0.0411091061374343
56,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.00287072366656252,0.0421381223913284
57,WP_PDGF_PATHWAY,37,Down,0.00326909621636375,0.0471438085938773
58,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Down,0.00337661573050627,0.0477352682933198
59,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,70,Down,0.00342625405025045,0.0477352682933198
60,WP_IL26_SIGNALING,31,Down,0.00385439696625503,0.052805238437694
61,WP_DOPAMINERGIC_NEUROGENESIS,4,Down,0.00398900364177453,0.0534706757697418
62,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,52,Down,0.00403306800209731,0.0534706757697418
63,WP_ASPIRIN_AND_MIRNAS,8,Down,0.00445100161550353,0.0580749734594271
64,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.00505946918173301,0.064011065008663
65,WP_PROTEASOME_DEGRADATION,57,Down,0.00506170222087968,0.064011065008663
66,WP_CHEMOKINE_SIGNALING,110,Down,0.00551461922567627,0.0686820758106954
67,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Down,0.00570479287239634,0.0699901453896984
68,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,15,Down,0.00643627209530702,0.0767556069257252
69,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.00644298890252438,0.0767556069257252
70,WP_CHOLESTEROL_METABOLISM,53,Down,0.00692893673056081,0.0813655141788712
71,WP_G13_SIGNALING,29,Down,0.00707448146370466,0.0819045600445807
72,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Down,0.00738195182683744,0.0842772833563941
73,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.007504105996713,0.0844982894424395
74,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.00835881535348333,0.0928506246022068
75,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.00854990909072516,0.0937070036343478
76,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Down,0.00877499759951083,0.0949085266683935
77,WP_RAC1PAK1P38MMP2_PATHWAY,51,Down,0.0092979587592227,0.0989994254865667
78,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.00939410606806838,0.0989994254865667
79,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.00978997730962102,0.100589861693317
80,WP_VEGFAVEGFR2_SIGNALING,342,Down,0.00983490673654803,0.100589861693317
81,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,41,Down,0.00991213965591081,0.100589861693317
82,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Down,0.0102703059135656,0.102943634096673
83,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,18,Down,0.0103945518613428,0.102943634096673
84,WP_HEART_DEVELOPMENT,17,Down,0.0113705079520438,0.110843893964721
85,WP_LUNG_FIBROSIS,33,Down,0.0114619598382011,0.110843893964721
86,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.0117793849200016,0.111971676849357
87,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.0119340465563454,0.111971676849357
88,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.012197458240173,0.111971676849357
89,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.0122321880410336,0.111971676849357
90,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,46,Down,0.0122596726477398,0.111971676849357
91,WP_NEOVASCULARIZATION_PROCESSES,22,Down,0.0126161590791148,0.113961349044312
92,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,91,Down,0.0133154286194861,0.118970460056713
93,WP_OSTEOBLAST_SIGNALING,3,Down,0.0134955429421482,0.119085458084308
94,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Down,0.0137002814291083,0.119085458084308
95,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.0137629179051207,0.119085458084308
96,WP_METABOLIC_EPILEPTIC_DISORDERS,58,Down,0.0140205391897795,0.120050866812487
97,WP_TARGET_OF_RAPAMYCIN_SIGNALING,33,Down,0.0141833144472912,0.12019262346055
98,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,15,Down,0.0145646829722613,0.122164993910191
99,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.0154908298214611,0.127433204780635
100,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.0156541504276668,0.127433204780635
101,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.0156578511956741,0.127433204780635
102,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.0160412191200554,0.128241431548575
103,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.0160691818120477,0.128241431548575
104,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,8,Down,0.0163766792583174,0.129182729773019
105,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,13,Down,0.0165014435841447,0.129182729773019
106,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.0178489974301505,0.135002225359331
107,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Down,0.0179398281105275,0.135002225359331
108,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,18,Down,0.0181427966226819,0.135002225359331
109,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.0181498027690989,0.135002225359331
110,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.0182022647355723,0.135002225359331
111,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.0182302275120265,0.135002225359331
112,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.0186104518988716,0.13658742375779
113,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Down,0.0188957663877109,0.137454159032729
114,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,30,Down,0.0192689787813399,0.138737367557073
115,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Down,0.0194097290377901,0.138737367557073
116,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.0197170473381474,0.139719076827217
117,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.0201521084218647,0.141581479681818
118,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.0206392878037298,0.142963556516354
119,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,37,Down,0.0206966705905671,0.142963556516354
120,WP_RETT_SYNDROME,32,Down,0.0216264850205647,0.147063551108069
121,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.0216568601073246,0.147063551108069
122,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.0220551958761425,0.147063551108069
123,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.022173142554225,0.147063551108069
124,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.0221847692669106,0.147063551108069
125,WP_TNFALPHA_SIGNALING,84,Down,0.0229997344640987,0.150525610640178
126,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.0230732687842609,0.150525610640178
127,WP_EFFECTS_OF_MFN2_MUTATION,18,Down,0.0235877008658405,0.1509474702979
128,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Up,0.0236557664313885,0.1509474702979
129,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.0238558109736916,0.1509474702979
130,WP_NAD_METABOLISM,12,Down,0.0240026977081746,0.1509474702979
131,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,84,Down,0.0240561053637772,0.1509474702979
132,WP_PRION_DISEASE_PATHWAY,28,Down,0.0246003988588459,0.153193392893722
133,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.0259452868090785,0.159769747631467
134,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,87,Down,0.0260451900031832,0.159769747631467
135,WP_CCL18_SIGNALING,20,Down,0.0263132991760123,0.160218754982831
136,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.0267935802600763,0.161407322446146
137,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.026901220407691,0.161407322446146
138,WP_NPHP1_DELETION_SYNDROME,10,Down,0.0275926318046853,0.16435611118443
139,WP_SPHINGOLIPID_PATHWAY,20,Down,0.028176479381615,0.166196615009189
140,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.0283059928239495,0.166196615009189
141,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.0298194153288586,0.173840846810793
142,WP_AMINO_ACID_METABOLISM,59,Down,0.0303699797188737,0.174718886002921
143,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.0303951346696079,0.174718886002921
144,WP_SELENIUM_MICRONUTRIENT_NETWORK,49,Down,0.0306773624146989,0.175116610450573
145,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,107,Down,0.0319259799067068,0.180772991481878
146,WP_AGERAGE_PATHWAY,54,Down,0.0321080982437398,0.180772991481878
147,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.0342939126117185,0.190474453538052
148,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.0342946704667052,0.190474453538052
149,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Down,0.0350066187509848,0.193123762505433
150,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.0356753360647266,0.193730078586823
151,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.0357319105955142,0.193730078586823
152,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.0359275767413223,0.193730078586823
153,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.0361906435516446,0.193730078586823
154,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Down,0.0362949295649278,0.193730078586823
155,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.0369442928530066,0.195923927259171
156,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.0379613151617164,0.200026929890582
157,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.0383669873115279,0.200532129129445
158,WP_NEUROINFLAMMATION,10,Down,0.0387029392857443,0.200532129129445
159,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.0387890614739438,0.200532129129445
160,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,52,Down,0.0396958944683052,0.202543000838726
161,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.039872094951657,0.202543000838726
162,WP_NOTCH_SIGNALING_WP268,35,Down,0.0401562764469232,0.202543000838726
163,WP_NOTCH_SIGNALING_WP61,49,Down,0.0401758167784166,0.202543000838726
164,WP_ALZHEIMERS_DISEASE,184,Down,0.0406564417741969,0.202543000838726
165,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Down,0.0406564417741969,0.202543000838726
166,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.0419033357503965,0.206713836229807
167,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Down,0.0419966066306299,0.206713836229807
168,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Down,0.0432022381160077,0.211382379353324
169,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,11,Down,0.0441712266079314,0.214844664329702
170,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,61,Down,0.0455590410720136,0.21916773497473
171,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Down,0.0455932879326993,0.21916773497473
172,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Down,0.0464485992899497,0.22198109660662
173,WP_B_CELL_RECEPTOR_SIGNALING,87,Down,0.0474582362951934,0.222102819882323
174,WP_SYNAPTIC_VESICLE_PATHWAY,23,Down,0.0475229382187125,0.222102819882323
175,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.047534945969974,0.222102819882323
176,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.047554861677967,0.222102819882323
177,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.048162690084994,0.223670798021837
178,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,45,Down,0.0487123376381585,0.224952480553743
179,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.0496735853823968,0.225716759049527
180,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,20,Down,0.0502552776797268,0.225716759049527
181,WP_ENDOTHELIN_PATHWAYS,12,Down,0.0509554909025659,0.225716759049527
182,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.0509596098926535,0.225716759049527
183,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.0510759772534366,0.225716759049527
184,WP_ANGIOGENESIS,14,Down,0.0510932598550599,0.225716759049527
185,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Down,0.0512312958567761,0.225716759049527
186,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.0513174872422122,0.225716759049527
187,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,12,Up,0.0513491897107804,0.225716759049527
188,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.0517677441188655,0.226346200349508
189,WP_NETRINUNC5B_SIGNALING,35,Down,0.0531574606343045,0.231192765298404
190,WP_HISTONE_MODIFICATIONS,37,Up,0.0547876392064842,0.236748670878346
191,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.0550109442065256,0.236748670878346
192,WP_PURINERGIC_SIGNALING,15,Down,0.0562028039910812,0.240618254586816
193,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.0565018314895989,0.240645106137048
194,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Down,0.0571657886724196,0.242217929323345
195,WP_RANKLRANK_SIGNALING,48,Down,0.0589083644909497,0.245776659869685
196,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.0593446289935007,0.245776659869685
197,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,80,Down,0.0594230177596241,0.245776659869685
198,WP_SLEEP_REGULATION,11,Up,0.0596067617473484,0.245776659869685
199,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.0596258955691323,0.245776659869685
200,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.0600986723039011,0.245776659869685
201,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.0600986723039011,0.245776659869685
202,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,13,Down,0.0604093152879789,0.245824045379795
203,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.0611902348148071,0.246678910797332
204,WP_16P112_DISTAL_DELETION_SYNDROME,21,Up,0.0616095178487683,0.246678910797332
205,WP_GPCRS_OTHER,13,Down,0.0617259986212248,0.246678910797332
206,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.0618197756986014,0.246678910797332
207,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.0627470836073199,0.24837710761554
208,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.0629279838924666,0.24837710761554
209,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.0631518436638051,0.24837710761554
210,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,29,Down,0.0636170427597828,0.249015281659721
211,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.0671220236445413,0.26040493921308
212,WP_INSULIN_SIGNALING,132,Down,0.067160397947899,0.26040493921308
213,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,272,Down,0.067641697375684,0.261039789872358
214,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.0682868638793994,0.261078149343564
215,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.0682868638793994,0.261078149343564
216,WP_MAPK_CASCADE,30,Down,0.069208080372853,0.261915317484193
217,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.0694953924291345,0.261915317484193
218,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.0696678466636004,0.261915317484193
219,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.0697803583078324,0.261915317484193
220,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.0708946696593163,0.264412941342062
221,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Down,0.0710891241321114,0.264412941342062
222,WP_CORI_CYCLE,11,Down,0.0723811888578897,0.265145366414558
223,WP_EGFEGFR_SIGNALING,141,Down,0.0724156367962281,0.265145366414558
224,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.073009755166296,0.265145366414558
225,WP_7OXOC_AND_7BETAHC_PATHWAYS,18,Down,0.0730955987370217,0.265145366414558
226,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.0732394122223243,0.265145366414558
227,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.0733015464112422,0.265145366414558
228,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.0735439702463737,0.265145366414558
229,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.0738901440285005,0.265230123980032
230,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.0749355638575716,0.267427177953322
231,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,22,Down,0.0755520719108277,0.267427177953322
232,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.0758035674733868,0.267427177953322
233,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.0758035674733868,0.267427177953322
234,WP_ARYLAMINE_METABOLISM,1,Up,0.0766241160514162,0.269166766642154
235,WP_HIPPO_SIGNALING_REGULATION,44,Down,0.0769743144014556,0.26924632526807
236,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.078651711150239,0.272798774403404
237,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.0786536612330982,0.272798774403404
238,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,72,Up,0.0797482783338032,0.274837495858913
239,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.0799245971938802,0.274837495858913
240,WP_CREATINE_PATHWAY,2,Down,0.0802445243383688,0.274837495858913
241,WP_VITAMIN_D_RECEPTOR_PATHWAY,84,Down,0.0813533939918255,0.277479211042658
242,WP_ACUTE_VIRAL_MYOCARDITIS,65,Down,0.0827828761283254,0.281188116435882
243,WP_TAR_SYNDROME,43,Down,0.0836185152366761,0.282857693516658
244,WP_BENZOAPYRENE_METABOLISM,5,Up,0.0845288089040357,0.284765085734088
245,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.0854864064449135,0.286085098619209
246,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,93,Down,0.0859275180200036,0.286085098619209
247,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.0860787912195417,0.286085098619209
248,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,47,Down,0.0863127791454548,0.286085098619209
249,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,136,Down,0.0874180314494241,0.288584826712557
250,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.0884465243480574,0.290812172056413
251,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,64,Up,0.0893299876223717,0.292546812054142
252,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Down,0.0899033487165141,0.292714852770683
253,WP_OVARIAN_INFERTILITY,21,Down,0.0900935009136045,0.292714852770683
254,WP_ATR_SIGNALING,10,Up,0.0914238705029528,0.294664147063335
255,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.0917342446977697,0.294664147063335
256,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Up,0.0921584277637378,0.294664147063335
257,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Down,0.0924114646573038,0.294664147063335
258,WP_GPCRS_CLASS_A_RHODOPSINLIKE,43,Down,0.0924858271804627,0.294664147063335
259,WP_FATTY_ACID_BETAOXIDATION,29,Down,0.0934530863958055,0.296596281920278
260,WP_BURN_WOUND_HEALING,60,Down,0.0944118440413578,0.297944542861035
261,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,32,Down,0.0946028293025914,0.297944542861035
262,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.0998250121527521,0.312785995312741
263,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.100076297770378,0.312785995312741
264,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.100561556253319,0.313112118334199
265,WP_NUCLEAR_RECEPTORS_METAPATHWAY,177,Down,0.101357649131004,0.314140069163865
266,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Down,0.101961435328939,0.314140069163865
267,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Down,0.102038197648117,0.314140069163865
268,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.104556772915857,0.320692788570277
269,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.107246092416752,0.327718542626654
270,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.107838542293371,0.32813757009675
271,WP_SEROTONIN_AND_ANXIETY,8,Down,0.108181607659634,0.32813757009675
272,WP_PLEURAL_MESOTHELIOMA,255,Down,0.11095840359504,0.335194031209603
273,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.111323565109759,0.335194031209603
274,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.111788574610333,0.335365723830999
275,WP_THERMOGENESIS,74,Down,0.113323593557511,0.338734523288269
276,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,8,Up,0.115296886379895,0.342730571892437
277,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.115694705613419,0.342730571892437
278,WP_LUNG_PATHOLOGY_OF_COVID19,14,Down,0.116045850967108,0.342730571892437
279,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Down,0.116739349494724,0.342730571892437
280,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,44,Down,0.116971698739882,0.342730571892437
281,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,46,Down,0.117162154138412,0.342730571892437
282,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,32,Down,0.120868986643805,0.352320237663856
283,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.123160571201291,0.357731411757813
284,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.124415732199256,0.360104689675311
285,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Down,0.126351374960579,0.364423965675774
286,WP_VITAMIN_B12_METABOLISM,23,Down,0.12744241533078,0.365879045481641
287,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.127763569259368,0.365879045481641
288,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,16,Down,0.128986353040635,0.365879045481641
289,WP_ENERGY_METABOLISM,41,Down,0.129188657133225,0.365879045481641
290,WP_ONCOSTATIN_M_SIGNALING,55,Down,0.129520135899793,0.365879045481641
291,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Down,0.129526523400435,0.365879045481641
292,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,27,Down,0.130883509440966,0.367482053393342
293,WP_TCELL_RECEPTOR_SIGNALING,74,Down,0.131153766411876,0.367482053393342
294,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.1314351869801,0.367482053393342
295,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.132013160909589,0.367846841585364
296,WP_PEPTIDE_GPCRS,15,Down,0.133930083335781,0.371512655834755
297,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,62,Down,0.134232674918397,0.371512655834755
298,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.135709942004995,0.373214731257893
299,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.135755723413759,0.373214731257893
300,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Up,0.136873456755801,0.375033271510895
301,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.138293066434202,0.376134874877112
302,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.138597559026969,0.376134874877112
303,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Down,0.139477048126535,0.376134874877112
304,WP_DISORDERS_IN_KETOLYSIS,4,Down,0.139764340234125,0.376134874877112
305,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.139889256345734,0.376134874877112
306,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.140021011815567,0.376134874877112
307,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Down,0.140892139291759,0.376593082880176
308,WP_ESTROGEN_METABOLISM_WP5276,9,Up,0.141107870470917,0.376593082880176
309,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,73,Down,0.141799092213005,0.377213119090906
310,WP_VITAMIN_D_METABOLISM,6,Down,0.144616402862344,0.383466719847894
311,WP_NRF2_PATHWAY,71,Down,0.146985087481349,0.38674860673065
312,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.147007482220125,0.38674860673065
313,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.147265588694274,0.38674860673065
314,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,61,Down,0.149628497853188,0.391620523648302
315,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Down,0.150073558332378,0.391620523648302
316,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.152189220158186,0.395884616993762
317,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.154977816122219,0.401866766096101
318,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.155509651918451,0.401977779487316
319,WP_CAMKK2_PATHWAY,30,Down,0.156164393366391,0.402404800461359
320,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.158355248928246,0.406775045684431
321,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.160985430546632,0.412243065138105
322,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.16571391116232,0.422635609422939
323,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.166072143362055,0.422635609422939
324,WP_KREBS_CYCLE_DISORDERS,11,Down,0.167732758456824,0.425544220529351
325,WP_IL18_SIGNALING,191,Down,0.168564503010228,0.425832842289915
326,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Up,0.168882611419115,0.425832842289915
327,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.169401128834892,0.425834030282205
328,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,13,Down,0.16992776645794,0.425855561062277
329,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.170651090515001,0.426368378125625
330,WP_WNT_SIGNALING_WP363,39,Down,0.171705303500012,0.427702301445483
331,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.172253076350065,0.427770479636716
332,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.174257856387122,0.428280033149084
333,WP_OREXIN_RECEPTOR_PATHWAY,119,Down,0.174534554049764,0.428280033149084
334,WP_DRAVET_SYNDROME,15,Down,0.174561765851036,0.428280033149084
335,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.175175155002333,0.428280033149084
336,WP_IL3_SIGNALING,46,Down,0.176382304378529,0.428280033149084
337,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,58,Up,0.176518244220215,0.428280033149084
338,WP_AEROBIC_GLYCOLYSIS,10,Down,0.177805867251012,0.428280033149084
339,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Down,0.177805867251012,0.428280033149084
340,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.177909935581652,0.428280033149084
341,WP_SULFATASE_AND_AROMATASE_PATHWAY,4,Up,0.178108485900898,0.428280033149084
342,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.17818950284305,0.428280033149084
343,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.179001244028544,0.428818848455543
344,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.180001989632046,0.428818848455543
345,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.180500391199048,0.428818848455543
346,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.180500391199048,0.428818848455543
347,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.182705985361196,0.430918939637344
348,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.18285724200295,0.430918939637344
349,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Down,0.183296830498646,0.430918939637344
350,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.183481300332203,0.430918939637344
351,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,176,Down,0.185045839320879,0.433355213452316
352,WP_INTEGRATED_CANCER_PATHWAY,41,Up,0.187487879684381,0.437826809944777
353,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.188062410170342,0.43792436589241
354,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.189079120385015,0.439048126995713
355,WP_15Q11Q13_COPY_NUMBER_VARIATION,36,Up,0.189713305748031,0.439279823450371
356,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.193352379904915,0.446448472701798
357,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.194089397660504,0.446894915621665
358,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,31,Down,0.195898232252452,0.447999536252982
359,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Down,0.196073265907592,0.447999536252982
360,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.196869902035431,0.447999536252982
361,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,38,Up,0.197028755059333,0.447999536252982
362,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.197624105302221,0.447999536252982
363,WP_FOLATE_METABOLISM,36,Down,0.197839211265003,0.447999536252982
364,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.199276181090864,0.450013793562336
365,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.199861238855676,0.450098461203741
366,WP_RETINOBLASTOMA_GENE_IN_CANCER,73,Up,0.203194359760859,0.456354545692421
367,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.204018914308855,0.456957895263975
368,WP_PPAR_SIGNALING,39,Down,0.207446585803138,0.463372536766792
369,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.210209814078126,0.468272268759402
370,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.211020748892105,0.468808258349487
371,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.212488697373832,0.470797059949569
372,WP_IRINOTECAN_PATHWAY,5,Up,0.213148463409481,0.470989346566111
373,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.21486695860046,0.473513780079297
374,WP_GPR40_PATHWAY,9,Up,0.215804067347166,0.474307335185482
375,WP_PURINE_METABOLISM,10,Down,0.216899221604971,0.474394505190071
376,WP_PROLACTIN_SIGNALING,69,Down,0.216997973176967,0.474394505190071
377,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Down,0.218866757121335,0.476239963903455
378,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.219000859313268,0.476239963903455
379,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Down,0.220331455374179,0.477365200794906
380,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.220679776523192,0.477365200794906
381,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.222220841479332,0.477408729971994
382,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,126,Down,0.222847172300648,0.477408729971994
383,WP_NEURAL_CREST_DIFFERENTIATION,41,Down,0.223386166502091,0.477408729971994
384,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.22434126800586,0.477408729971994
385,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.224430430143695,0.477408729971994
386,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.224765791589484,0.477408729971994
387,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,18,Down,0.225891903946888,0.477408729971994
388,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.226320438620814,0.477408729971994
389,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.226359511895729,0.477408729971994
390,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.226513307296741,0.477408729971994
391,WP_COMPLEMENT_SYSTEM,51,Up,0.227517224198111,0.477408729971994
392,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.227669370010975,0.477408729971994
393,WP_HEPATITIS_B_INFECTION,117,Down,0.228905235854171,0.478778890259868
394,WP_OSTEOPONTIN_SIGNALING,11,Down,0.230610294038741,0.48051201406782
395,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.231458006586534,0.48051201406782
396,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Down,0.231487539623913,0.48051201406782
397,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.232729534039423,0.481873241764246
398,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.233700669673725,0.482668217265834
399,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,31,Down,0.236735134992521,0.485390416089088
400,WP_HUNGER_AND_SATIETY,2,Up,0.236802527354375,0.485390416089088
401,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.237164681735243,0.485390416089088
402,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.237835681479955,0.485390416089088
403,WP_SMALL_CELL_LUNG_CANCER,70,Down,0.238585533548141,0.485390416089088
404,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.238742789682427,0.485390416089088
405,WP_SMALL_LIGAND_GPCRS,7,Down,0.239152212306668,0.485390416089088
406,WP_BARDETBIEDL_SYNDROME,65,Up,0.247291106018935,0.499459091072168
407,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.247299087671986,0.499459091072168
408,WP_IL9_SIGNALING,15,Up,0.250517270481842,0.504198212599318
409,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,74,Down,0.250872346658298,0.504198212599318
410,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.254735083267488,0.510712776697257
411,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.256717712424146,0.512790182770705
412,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Up,0.257018923724489,0.512790182770705
413,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,50,Down,0.258022317357771,0.513545629220551
414,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.259880265624552,0.515268418368173
415,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Down,0.260141598081255,0.515268418368173
416,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.261580260463924,0.515867041557485
417,WP_NUCLEAR_RECEPTORS,20,Down,0.26186979659916,0.515867041557485
418,WP_KETOGENESIS_AND_KETOLYSIS,6,Up,0.262326549113173,0.515867041557485
419,WP_ATM_SIGNALING,34,Up,0.269253413634262,0.52613014511342
420,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Down,0.269520607902686,0.52613014511342
421,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.269785517462395,0.52613014511342
422,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.270105743598374,0.52613014511342
423,WP_FERROPTOSIS,50,Down,0.275079444017781,0.534186342094839
424,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.275541373537971,0.534186342094839
425,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Down,0.276406884998248,0.534603434043671
426,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.279663201089013,0.53866107273464
427,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.279815423427848,0.53866107273464
428,WP_RETINOL_METABOLISM,6,Down,0.280685960196153,0.539074437572985
429,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.282097372031861,0.54052223731979
430,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.285041541347466,0.543856803893227
431,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.285160927588785,0.543856803893227
432,WP_G_PROTEIN_SIGNALING,62,Down,0.2883035153589,0.54857752228013
433,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.289959850232007,0.550454958177158
434,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Up,0.291381816941426,0.551879846833762
435,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.293046244435941,0.553131530218697
436,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.293388500213324,0.553131530218697
437,WP_LEPTIN_SIGNALING,70,Down,0.296003495163671,0.553957265756399
438,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,60,Up,0.296559598554471,0.553957265756399
439,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,48,Down,0.296932453612882,0.553957265756399
440,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Up,0.297131139833398,0.553957265756399
441,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.298022441606083,0.553957265756399
442,WP_BLADDER_CANCER,29,Down,0.298194847645608,0.553957265756399
443,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.29854387923368,0.553957265756399
444,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.300658101109816,0.555015913898036
445,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Down,0.300906453530892,0.555015913898036
446,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.301140021409397,0.555015913898036
447,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.304976260820495,0.560609612391352
448,WP_NRF2ARE_REGULATION,20,Up,0.305557348474936,0.560609612391352
449,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.306221065649291,0.560609612391352
450,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.308117137572777,0.56282730463294
451,WP_BENZENE_METABOLISM,3,Up,0.310432475155305,0.564372096148756
452,WP_ACE_INHIBITOR_PATHWAY,5,Down,0.31087600950307,0.564372096148756
453,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,82,Down,0.311022578534533,0.564372096148756
454,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.313294243751275,0.566416682331912
455,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.313527482312677,0.566416682331912
456,WP_IL19_SIGNALING,20,Down,0.315025229580219,0.567874427006448
457,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.319413387787057,0.57446844313369
458,WP_GLUTATHIONE_METABOLISM,10,Down,0.32008095736646,0.57446844313369
459,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.321675140912131,0.575054184730863
460,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.321806478073232,0.575054184730863
461,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,10,Down,0.325294729461877,0.577948329830658
462,WP_MALE_INFERTILITY,68,Up,0.325670785041363,0.577948329830658
463,WP_DNA_MISMATCH_REPAIR,21,Up,0.325696495785312,0.577948329830658
464,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.326238473286406,0.577948329830658
465,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.330381599945059,0.584029408935137
466,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.333213224922797,0.587603569962514
467,WP_APOPTOSIS_MODULATION_AND_SIGNALING,79,Down,0.333833171742694,0.587603569962514
468,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,23,Down,0.334625544828968,0.587739738994469
469,WP_DNA_DAMAGE_RESPONSE,59,Up,0.33686271613472,0.590314622961517
470,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.337527825780916,0.590314622961517
471,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.338537681760751,0.590823724856342
472,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.34056374891106,0.593100427129007
473,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.343256761644227,0.596526549834153
474,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.347270746970656,0.602229016898479
475,WP_MATRIX_METALLOPROTEINASES,8,Down,0.348738817381196,0.60271365998677
476,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.349508517200979,0.60271365998677
477,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Up,0.349749897583563,0.60271365998677
478,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Down,0.352426053752252,0.604953248189296
479,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.35252141834875,0.604953248189296
480,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.355627379143118,0.609011886782589
481,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.361354823049252,0.617533606125749
482,WP_TGFB_SMAD_SIGNALING,7,Down,0.362614102496472,0.617638658701708
483,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.362919065879471,0.617638658701708
484,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.36573693206245,0.621148260651516
485,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.369807037854414,0.626765742507893
486,WP_P38_MAPK_SIGNALING,31,Down,0.371716754861729,0.628706116247615
487,WP_ENDOMETRIAL_CANCER,49,Down,0.37311059442961,0.629767779509526
488,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.374113001922529,0.630165753238358
489,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.375129192807273,0.630585268890753
490,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,4,Down,0.379311200768963,0.636043381481986
491,WP_MONOAMINE_GPCRS,3,Down,0.379923723002014,0.636043381481986
492,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Down,0.381359987142073,0.636078853116649
493,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.381492548158769,0.636078853116649
494,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,38,Down,0.383948630615243,0.638878085760586
495,WP_ADIPOGENESIS,86,Down,0.385683114397922,0.639521113407421
496,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.385891085462385,0.639521113407421
497,WP_KININKALLIKREIN_PATHWAY,2,Down,0.390731569089312,0.646240140425381
498,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.392087193696193,0.646914334460485
499,WP_ALLOGRAFT_REJECTION,50,Down,0.392813304069916,0.646914334460485
500,WP_TGFBETA_RECEPTOR_SIGNALING,35,Down,0.393701775581553,0.646914334460485
501,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.394287203850003,0.646914334460485
502,WP_NUCLEOTIDE_GPCRS,5,Up,0.395968439105113,0.648378599490843
503,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.398661410058511,0.651490415642337
504,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Down,0.400157775712916,0.652638277055589
505,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.403173322167686,0.656254397667006
506,WP_ESTROGEN_SIGNALING,21,Down,0.405845630245254,0.659298632532805
507,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Down,0.412299737497591,0.66846229629787
508,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Down,0.413871348583278,0.669689465620974
509,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.415709315553738,0.671341959499357
510,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.417478433495313,0.671972110635834
511,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.417734487268749,0.671972110635834
512,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.419510891827216,0.673511627113226
513,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Down,0.422368251700716,0.676777198631556
514,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Up,0.423262541338309,0.676890678949592
515,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.429632080213857,0.684427768690948
516,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.429640789105266,0.684427768690948
517,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Up,0.431325651237537,0.685243780202998
518,WP_IRON_METABOLISM_IN_PLACENTA,8,Up,0.431820289714298,0.685243780202998
519,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.434159363633151,0.687628125060597
520,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,22,Up,0.439849588480537,0.694227021975212
521,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Up,0.440014937285992,0.694227021975212
522,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.442391785056505,0.69663993738783
523,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.44444218686103,0.698262170336049
524,WP_APOPTOSIS,72,Down,0.445120896905218,0.698262170336049
525,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.446825310884693,0.699600772470891
526,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Down,0.453980386672362,0.706351812473941
527,WP_RAS_SIGNALING,117,Down,0.45403229544207,0.706351812473941
528,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.454228860744361,0.706351812473941
529,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.454574341604276,0.706351812473941
530,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Up,0.456447014727212,0.707517590656296
531,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.457046034840016,0.707517590656296
532,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.45907618581557,0.708209774098425
533,WP_OPIOID_RECEPTOR_PATHWAYS,25,Down,0.459789410806326,0.708209774098425
534,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.460077882443502,0.708209774098425
535,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,33,Down,0.464291754974046,0.710185363395963
536,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,22,Down,0.464748006914927,0.710185363395963
537,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.465063670235935,0.710185363395963
538,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,52,Down,0.465209961166731,0.710185363395963
539,WP_CILIOPATHIES,128,Up,0.465681156776672,0.710185363395963
540,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.466826910258815,0.710614296727307
541,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.469817096821292,0.713844091658229
542,WP_PYRIMIDINE_METABOLISM,71,Down,0.470774715161775,0.713979365060848
543,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.473312136295248,0.71616635723063
544,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.474240242233905,0.71616635723063
545,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.474830492324445,0.71616635723063
546,WP_COPPER_HOMEOSTASIS,39,Up,0.478256303599138,0.720012237286614
547,WP_TP53_NETWORK,16,Up,0.479368389573143,0.720367122905161
548,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.481329096041052,0.721993644061578
549,WP_JOUBERT_SYNDROME,72,Up,0.484063322282066,0.724772406039815
550,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.496678029455922,0.742307891295942
551,WP_PHOSPHOINOSITIDES_METABOLISM,39,Up,0.501250847917692,0.747782571666684
552,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.504024056197035,0.748223951953352
553,WP_HEME_BIOSYNTHESIS,8,Down,0.504024056197035,0.748223951953352
554,WP_KALLMANN_SYNDROME,11,Down,0.50433684364941,0.748223951953352
555,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.507203129587287,0.748223951953352
556,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.507936897041879,0.748223951953352
557,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Down,0.509343438258158,0.748223951953352
558,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.509592287974068,0.748223951953352
559,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Down,0.509894796283924,0.748223951953352
560,WP_MONOAMINE_TRANSPORT,12,Down,0.510496577957542,0.748223951953352
561,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.510649193486411,0.748223951953352
562,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,5,Down,0.512718293400955,0.749918927358692
563,WP_VITAMIN_B12_DISORDERS,9,Down,0.514947456602411,0.751345642716082
564,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,49,Down,0.516005529249234,0.751345642716082
565,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.516930156473013,0.751345642716082
566,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.517349919437108,0.751345642716082
567,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.518895932936902,0.751855743828385
568,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Down,0.519530489652704,0.751855743828385
569,WP_UROTENSINIIMEDIATED_SIGNALING,48,Down,0.522895016950682,0.755381157413736
570,WP_ERBB_SIGNALING,69,Down,0.523804452221204,0.755381157413736
571,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Down,0.526893415171513,0.75670989168394
572,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.527519282007311,0.75670989168394
573,WP_GLYOXYLATE_METABOLISM,5,Down,0.528149580581916,0.75670989168394
574,WP_SERINE_METABOLISM,5,Up,0.529088411236717,0.75670989168394
575,WP_FRAGILE_X_SYNDROME,84,Down,0.529812817689508,0.75670989168394
576,WP_CILIARY_LANDSCAPE,185,Down,0.530249267165389,0.75670989168394
577,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Up,0.532189019729802,0.757692649027126
578,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Down,0.53326915965023,0.757692649027126
579,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.533703216285531,0.757692649027126
580,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.537192889300176,0.758607043726054
581,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.538006618931721,0.758607043726054
582,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Up,0.538334930140186,0.758607043726054
583,WP_ECTODERM_DIFFERENTIATION,78,Down,0.538623846069865,0.758607043726054
584,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.539705046413678,0.758607043726054
585,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Down,0.539884574914527,0.758607043726054
586,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.543162636176427,0.759997994895426
587,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.543590089530565,0.759997994895426
588,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.543648200728115,0.759997994895426
589,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.544855124913031,0.760392041899001
590,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.545834045200633,0.760467093482916
591,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Down,0.548561381200841,0.761717860000243
592,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Down,0.548585125450297,0.761717860000243
593,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Down,0.551280400078737,0.764169458456529
594,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.556478282117879,0.76916176015358
595,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.556753342203625,0.76916176015358
596,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.558048380285895,0.769286547186475
597,WP_WNT_SIGNALING_WP428,60,Down,0.558715412007696,0.769286547186475
598,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Down,0.559665627923318,0.769306264469845
599,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Down,0.562469589694022,0.771869787526689
600,WP_CIRCADIAN_RHYTHM_GENES,121,Up,0.563783635585154,0.77238358075166
601,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.569083304488357,0.77609716549348
602,WP_4P163_COPY_NUMBER_VARIATION,22,Down,0.569659582670262,0.77609716549348
603,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Down,0.569779555598166,0.77609716549348
604,WP_FOXP3_IN_COVID19,9,Up,0.570270909924649,0.77609716549348
605,WP_NRXN1_DELETION_SYNDROME,2,Up,0.5844729954898,0.794110417012588
606,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Down,0.586626535733089,0.794969834556518
607,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.587429619559268,0.794969834556518
608,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Down,0.589798832148817,0.794969834556518
609,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.591165150281633,0.794969834556518
610,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.592445452601327,0.794969834556518
611,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,3,Down,0.59250751273491,0.794969834556518
612,WP_NEPHROTIC_SYNDROME,27,Down,0.593168285089902,0.794969834556518
613,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.594178426284201,0.794969834556518
614,WP_GASTRIC_CANCER_NETWORK_1,18,Up,0.594325545645324,0.794969834556518
615,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Down,0.594776701036811,0.794969834556518
616,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Down,0.598477493852877,0.798617694719261
617,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,72,Down,0.599755566329421,0.799026054331903
618,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Down,0.60245774241677,0.801327288457257
619,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.604714041605232,0.801827855769427
620,WP_ENDODERM_DIFFERENTIATION,84,Down,0.604785000702001,0.801827855769427
621,WP_MTHFR_DEFICIENCY,18,Up,0.607546909156747,0.803850843028621
622,WP_FOXA2_PATHWAY,9,Down,0.608266696306329,0.803850843028621
623,WP_ONECARBON_METABOLISM,22,Up,0.612542843246733,0.808202595744486
624,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Down,0.614784253862822,0.809860026723141
625,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.623967902933158,0.82064258593769
626,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.625951874054975,0.821936805867715
627,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Down,0.627448524329132,0.822588017541541
628,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.63506403139919,0.82974074959793
629,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.635718217262937,0.82974074959793
630,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.635932691297683,0.82974074959793
631,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Down,0.643699750815311,0.83854389091947
632,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.645038977387465,0.838958923121038
633,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Down,0.648503319451915,0.842132272653197
634,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.650811341917935,0.842189771172168
635,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,27,Down,0.65123561176538,0.842189771172168
636,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Down,0.651621282804743,0.842189771172168
637,WP_PPARALPHA_PATHWAY,15,Down,0.655716750670575,0.844983521847682
638,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.656543562949281,0.844983521847682
639,WP_ID_SIGNALING,12,Up,0.656866752385242,0.844983521847682
640,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.658645951298992,0.845948393699643
641,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.661293765151571,0.84622523828622
642,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.661716833305822,0.84622523828622
643,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.66271149541953,0.84622523828622
644,WP_SPINA_BIFIDA,10,Down,0.662979383766819,0.84622523828622
645,WP_DOPAMINE_METABOLISM,7,Down,0.664025437345452,0.846246371314669
646,WP_IL6_SIGNALING,38,Up,0.665992940827793,0.847439933994498
647,WP_ZINC_HOMEOSTASIS,21,Down,0.670177529944188,0.850651403015634
648,WP_5Q35_COPY_NUMBER_VARIATION,77,Down,0.6707799774497,0.850651403015634
649,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Down,0.67199192855621,0.850651403015634
650,WP_MEASLES_VIRUS_INFECTION,100,Up,0.672656218929638,0.850651403015634
651,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.676298398963958,0.853943600535136
652,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.677473531255483,0.854115402901851
653,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.67936127154204,0.855183713947254
654,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Down,0.680671217191306,0.855522539038614
655,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.682962407889746,0.857091754634155
656,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.685093612926063,0.858455716196987
657,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.68760674345015,0.860293368517539
658,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Down,0.690727766821558,0.861313625510122
659,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.69079170238439,0.861313625510122
660,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.692337286528536,0.861313625510122
661,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Down,0.693460490007394,0.861313625510122
662,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.694315342465758,0.861313625510122
663,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Up,0.69470916510123,0.861313625510122
664,WP_ALPHA_6_BETA_4_SIGNALING,26,Up,0.698811303234169,0.864200616764587
665,WP_MELANOMA,55,Down,0.69914040164045,0.864200616764587
666,WP_NONSMALL_CELL_LUNG_CANCER,61,Up,0.70430321195095,0.869275135470993
667,WP_IDO_METABOLIC_PATHWAY,8,Down,0.707638052443708,0.87208167782418
668,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,87,Down,0.710736450068296,0.874588865203801
669,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Up,0.712042397275235,0.874886174230557
670,WP_OSTEOCLAST_SIGNALING,9,Down,0.714250478231991,0.876289392696562
671,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Down,0.715345690023215,0.876325122502359
672,WP_IRON_METABOLISM_DISORDERS,10,Up,0.717684699529707,0.877882177103303
673,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.720531477737402,0.880054791530675
674,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,65,Down,0.724102167726983,0.882769845817805
675,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.724902245653307,0.882769845817805
676,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.72706245878001,0.884090741297586
677,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Up,0.729161640015761,0.884478725898593
678,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.729533547638985,0.884478725898593
679,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.735742808715087,0.88925364775776
680,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.736554347528402,0.88925364775776
681,WP_CANCER_PATHWAYS,308,Down,0.736717438105881,0.88925364775776
682,WP_CYTOSINE_METHYLATION,7,Down,0.738243856247885,0.889789515888213
683,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.743815190862813,0.893498043595054
684,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,36,Down,0.743896565112305,0.893498043595054
685,WP_TRYPTOPHAN_METABOLISM,19,Down,0.744581702995878,0.893498043595054
686,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Up,0.748037673657843,0.894809669051005
687,WP_GASTRIC_CANCER_NETWORK_2,26,Up,0.748341194262991,0.894809669051005
688,WP_MRNA_PROCESSING,124,Up,0.749721728242943,0.894809669051005
689,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Down,0.750029029168057,0.894809669051005
690,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.755086677236584,0.898197615239309
691,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.756097420050522,0.898197615239309
692,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.757232504238669,0.898197615239309
693,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,166,Down,0.757239595329491,0.898197615239309
694,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.760884708567645,0.899949203973303
695,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.760905957130712,0.899949203973303
696,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.762183295549093,0.900164754226084
697,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Down,0.763831731595124,0.900817336257091
698,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Up,0.766010410640693,0.901463631476132
699,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Up,0.767036444599642,0.901463631476132
700,WP_VALPROIC_ACID_PATHWAY,9,Down,0.768408525352522,0.901463631476132
701,WP_BLOOD_CLOTTING_CASCADE,5,Down,0.769581601601442,0.901463631476132
702,WP_BDNFTRKB_SIGNALING,27,Down,0.770235342910313,0.901463631476132
703,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,52,Up,0.770959772418152,0.901463631476132
704,WP_IL11_SIGNALING,40,Up,0.772180878119283,0.901608923031322
705,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.775922340441975,0.90469243098341
706,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.780320744880697,0.908532085399339
707,WP_EICOSANOID_SYNTHESIS,13,Up,0.787453849017216,0.915540401544769
708,WP_TYPE_II_INTERFERON_SIGNALING,30,Up,0.788826713690885,0.915841184539417
709,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.793220831599689,0.919600317389392
710,WP_PREIMPLANTATION_EMBRYO,21,Down,0.795278672243677,0.919600317389392
711,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.795420712486445,0.919600317389392
712,WP_KLEEFSTRA_SYNDROME,25,Up,0.797788192260037,0.921041986008077
713,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.799391111480977,0.921598167794338
714,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.800516340930282,0.921602846281081
715,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.803225942024253,0.923428985096414
716,WP_DNA_REPLICATION,36,Up,0.80638429892648,0.924944943248524
717,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.806795041738676,0.924944943248524
718,WP_PI3KAKT_SIGNALING,178,Up,0.808528355239064,0.925039462111209
719,WP_HIPPOYAP_SIGNALING,16,Down,0.809128191311386,0.925039462111209
720,WP_TCELL_ACTIVATION_SARSCOV2,61,Up,0.818541148218467,0.934220242871304
721,WP_STEROID_BIOSYNTHESIS,3,Up,0.82504927254114,0.934220242871304
722,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Up,0.826414094732035,0.934220242871304
723,WP_TRANSLATION_FACTORS,49,Down,0.827793907296729,0.934220242871304
724,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.828271218700706,0.934220242871304
725,WP_GLUCURONIDATION,7,Up,0.829063442061427,0.934220242871304
726,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.829450219893119,0.934220242871304
727,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,41,Down,0.829522183419484,0.934220242871304
728,WP_GALANIN_RECEPTOR_PATHWAY,10,Down,0.831009737579406,0.934220242871304
729,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Up,0.831485916909292,0.934220242871304
730,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.831642839734311,0.934220242871304
731,WP_ALSTROM_SYNDROME,27,Up,0.832576516066591,0.934220242871304
732,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.833069875942416,0.934220242871304
733,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.833069875942416,0.934220242871304
734,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.836073612723815,0.93582994950408
735,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.836812789199391,0.93582994950408
736,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Up,0.838004550609113,0.93582994950408
737,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.839893596433303,0.93582994950408
738,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Up,0.84035057030506,0.93582994950408
739,WP_CELL_CYCLE,96,Up,0.842337680413663,0.93582994950408
740,WP_METHYLATION_PATHWAYS,5,Up,0.843242024425438,0.93582994950408
741,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.843613129662437,0.93582994950408
742,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.846744428628561,0.936013584929293
743,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.847360912495927,0.936013584929293
744,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,19,Up,0.847713132119664,0.936013584929293
745,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.848333480258301,0.936013584929293
746,WP_MIRNA_BIOGENESIS,6,Up,0.854890890549016,0.941416256680053
747,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.855520612822384,0.941416256680053
748,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,48,Up,0.858465257763867,0.942562649449847
749,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.858855747491405,0.942562649449847
750,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.862572184511878,0.945379114225018
751,WP_SILDENAFIL_TREATMENT,11,Up,0.864591297654835,0.946330288511684
752,WP_BREAST_CANCER_PATHWAY,88,Up,0.866415235852723,0.946454970371092
753,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.867008020303445,0.946454970371092
754,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.8743882031903,0.952064326714966
755,WP_KIT_RECEPTOR_SIGNALING,52,Down,0.875544435024723,0.952064326714966
756,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.87669629715795,0.952064326714966
757,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Down,0.876896667682708,0.952064326714966
758,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.877937663807718,0.952064326714966
759,WP_IL5_SIGNALING,37,Up,0.881738630142068,0.952882886466796
760,WP_CHOLESTASIS,9,Down,0.884704285386434,0.952882886466796
761,WP_IL2_SIGNALING,37,Down,0.885014816716131,0.952882886466796
762,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,28,Down,0.885896355592721,0.952882886466796
763,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.886262998794672,0.952882886466796
764,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.887964756567551,0.952882886466796
765,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,62,Up,0.888114366778708,0.952882886466796
766,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.889045046726692,0.952882886466796
767,WP_G1_TO_S_CELL_CYCLE_CONTROL,52,Down,0.889125515717801,0.952882886466796
768,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Up,0.891253082051172,0.953550608770704
769,WP_GLIOBLASTOMA_SIGNALING,69,Down,0.893156217864275,0.953550608770704
770,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.893319777664475,0.953550608770704
771,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Down,0.89820985613658,0.953550608770704
772,WP_IL17_SIGNALING,25,Up,0.899020124663453,0.953550608770704
773,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.899697448942502,0.953550608770704
774,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.900408883318116,0.953550608770704
775,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Up,0.90237214844509,0.953550608770704
776,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.902663079923441,0.953550608770704
777,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.902877470405641,0.953550608770704
778,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.903603048810655,0.953550608770704
779,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,15,Down,0.903669007581969,0.953550608770704
780,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.904836315086189,0.953558270513907
781,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Up,0.907002068086378,0.954616773325228
782,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,22,Down,0.912055856282493,0.958708329749629
783,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.915192642317063,0.960776950171936
784,WP_AUTOPHAGY,27,Down,0.918209809599398,0.96271487690141
785,WP_CELLULAR_PROTEOSTASIS,6,Up,0.920289735876948,0.963666449542485
786,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.922106989237538,0.964340897141547
787,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.923549710125203,0.964622441833439
788,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Up,0.926491328738949,0.966098573701291
789,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.927313594465108,0.966098573701291
790,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.929429830303449,0.966123469573372
791,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.929688156243963,0.966123469573372
792,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.93428898725524,0.967313928893814
793,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,26,Up,0.935506570300795,0.967313928893814
794,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.935954189622687,0.967313928893814
795,WP_TCA_CYCLE_IN_SENESCENCE,10,Down,0.936710972842069,0.967313928893814
796,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Up,0.936717624573571,0.967313928893814
797,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.945196305067274,0.974844871725595
798,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.950288819528267,0.978868934401297
799,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.957902435174745,0.982230480015178
800,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.958167617357952,0.982230480015178
801,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.959071122440341,0.982230480015178
802,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.959748923160146,0.982230480015178
803,WP_ACUTE_MYELOID_LEUKEMIA,56,Up,0.959873307092884,0.982230480015178
804,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.96072178337251,0.982230480015178
805,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Down,0.962701393364787,0.98281218255638
806,WP_BASE_EXCISION_REPAIR,29,Down,0.96368201841903,0.98281218255638
807,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Down,0.966453449240575,0.984417267999693
808,WP_MACROPHAGE_MARKERS,8,Up,0.970399443420448,0.986529527512363
809,WP_IL4_SIGNALING,50,Down,0.970927479023724,0.986529527512363
810,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.973057640292501,0.987473309037575
811,WP_TRANSSULFURATION_PATHWAY,8,Down,0.977249376309299,0.98850162207536
812,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.977365869523344,0.98850162207536
813,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.97767861161468,0.98850162207536
814,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.982190360217326,0.991289226329975
815,WP_NEPHROGENESIS,4,Up,0.982932586121613,0.991289226329975
816,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Down,0.984053538546545,0.991289226329975
817,WP_PDGFRBETA_PATHWAY,28,Up,0.986317946042665,0.992226734577425
818,WP_PRIMARY_OVARIAN_INSUFFICIENCY,88,Down,0.987398380637876,0.992226734577425
819,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.990079549325077,0.992779987324838
820,WP_IL7_SIGNALING,23,Down,0.990364464241323,0.992779987324838
821,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Up,0.992921584108751,0.993052102785317
822,WP_MESODERMAL_COMMITMENT_PATHWAY,77,Down,0.993052102785317,0.993052102785317
